linezolid

Clinical efficacy analysis of Linezolid in treatment of 40 children with infectious diseases

利奈唑胺治疗儿童感染性疾病40例临床疗效分析

Linezolid Treatment in Complicated Skin and Soft Tissue Infections : A Clinical Analysis

利奈唑胺治疗复杂性皮肤软组织感染的临床分析

Linezolid in the treatment of severe pulmonary infection in 30 patients following renal transplantation

利奈唑胺治疗肾移植后重症肺部感染30例

The Synthetic Method and Market Prospects of Linezolid

利奈唑胺（斯沃）的合成和市场前景

New synthetic method of linezolid

恶丙嗪含量紫外分光光度测定法利奈唑酮合成新工艺

Clinical Therapeutic Effect of Linezolid to Repeatedly MRSA Infection

利奈唑胺对耐甲氧西林金黄色葡萄球菌反复感染的临床疗效观察

The process of Linezolid was researched particularly .

重点研究了利奈唑酮的合成工艺。

A case report : refractory infection of billiary tract treated with Linezolid

利奈唑胺治疗难治性胆道感染1例报告

Effects of linezolid for treatment of methicillin-resistant Staphylococcus aureus infection in 21 aged patients

利奈唑胺治疗21例高龄病人耐甲氧西林金黄色葡萄球菌感染

A study of antibacterial activity in vitro of linezolid against gram-positive cocci

利奈唑胺对革兰阳性球菌的体外抗菌活性研究

Clinical Evaluation of Linezolid in the Treatment of Gram positive Cocci Infections for the Elderly Patients

利奈唑胺治疗高龄革兰阳性球菌感染患者的临床观察

Survey on the antibacterial activity of linezolid to hetero-VRS in vitro

利奈唑胺对h-VRS体外抗菌活性研究

Efficacy and Safety of Linezolid in the Treatment of Gram-positive Cocci Infections in ICU

利奈唑胺治疗ICU革兰阳性球菌感染的疗效及安全性观察

Linezolid could be an effective agent for the treatment of nocardiosis , whether it could reduce the treatment course need to be further studied .

利奈唑胺可有效治疗奴卡菌病，是否可以适当缩短疗程值得探讨。

AIM To evaluate the efficacy and safety of linezolid in the treatment of children with gram-positive coccobacterial infections .

目的观察利奈唑胺对儿童革兰阳性细菌感染的疗效及安全性。

Study on the Synthetic Process of New Type of Antibacterial Agent : Linezolid and Its Analogs ; Synthesis and Antifungal Activity of Novel Triazole Compounds

新型氮唑类化合物的合成及其抗真菌活性研究

Vancomycin , linezolid against gram-positive bacteria are most sensitive , and the sensitivity ratio is above 94 % .

革兰阳性球菌对红霉素、青霉素有较高的耐药率，耐药率达80%以上，对万古霉素、利奈唑烷最敏感，敏感率在94%以上。

A randomized , double-blinded , controlled , multicenter clinical trial of linezolid versus vancomycin in the treatment of gram positive bacterial infection

利奈唑胺与万古霉素治疗革兰阳性菌感染的随机、双盲、对照、多中心临床试验

Advances in mechanisms of bacterial resistance to linezolid and related detection methods Linezolid versus Vancomycin for Gram-positive Bacteraemia : A Systematic Review

细菌对利奈唑胺的耐药机制及检测方法研究进展利奈唑胺与万古霉素治疗革兰氏阳性菌血症效果比较的系统评价

Starting from 3,4-difluoro - nitrobenzene , linezolid was prepared through 7 steps in an overall yield of 35 % .

从3,4-二氟硝基苯出发，经7步反应，以35%的总收率合成了列奈唑酮。

Conclusions : Linezolid could provide conspicuous effectiveness and satisfactory bacterium clearance rate in treatment of gram-positive cocci infection in ICU , cause less adverse reaction .

结论：利奈唑胺治疗重症患者的革兰阳性球菌感染的疗效确切，不良反应较少。

In vitro activity of antimicrobial agents of linezolid , teicoplanin and vancomycin against gram-positire cocci clinical isolates

利奈唑胺、替考拉宁和万古霉素等抗菌药物对常见需氧革兰阳性球菌的体外抗菌活性

Conclusion Insertion of methylene group between 4-position of phenyl and morpholinyl group in linezolid derivatives can not increase the antibacterial activity .

结论在吗啉恶酮结构中苯环4位和吗啉基之间插入亚甲基，不能提高化合物的抗菌活性。

The Study of MPC of Fluoroquinolone Against Escherichia Coli ; Comparison of linezolid and vancomycin in preventing the drug resistant mutants for staphylococcus aureus

氟喹诺酮类药物对大肠埃希菌防耐药突变体选择浓度的研究利奈唑胺与万古霉素对金黄色葡萄球菌耐药突变选择的比较

The totally synthetic oxazolidinones are a new class of antibacterial agents . One of them , Linezolid , has been launched into the international market for treatment of infections caused by drug-resistant Gram-positive bacteria .

全合成的恶唑烷酮化合物是一类新型的抗感染药物，其代表药物吗啉恶酮（Linezolid）已在国际上上市，用于治疗由耐药的革兰阳性菌引起的感染。